Rare germline mutations in BAP1 contribute to predispositions in malignant mesothelioma, among other cancers, despite lack of exposure to high levels of asbestos or other carcinogens [68], suggesting that BAP1 may serve as a predictive biomarker. This evidence concerns the gene BAP1 and malignant mesothelioma.